TENX
Tenax Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$343.33M
P/E Ratio
—
EPS
$-1.34
Beta
1.00
52W High
$18.38
52W Low
$5.34
50-Day MA
$13.77
200-Day MA
$10.15
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.29
PEG Ratio
1.44
About Tenax Therapeutics Inc
Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-19.49M |
| Operating Margin | 0.00% |
| Return on Equity | -55.60% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.29 |
| Price-to-Book | 3.38 |
| Price-to-Sales (TTM) | 414.72 |
| EV/Revenue | 263.34 |
| EV/EBITDA | -0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $25.78M |
| Float | $21.99M |
| % Insiders | 0.07% |
| % Institutions | 31.12% |
Historical Volatility
HV 10-Day
85.98%
HV 20-Day
71.92%
HV 30-Day
82.47%
HV 60-Day
90.72%
HV Rank
75.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($29.57 target)
1
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026